Prosoma 350 — Carisoprodol Tablets

Prosoma 350 — Carisoprodol Tablets starts from €52.00. Several pack sizes are available — the larger the pack, the lower the per-unit price. European delivery is free on orders over €110, otherwise €20 standard (3–5 working days to most countries, 2–7 by country).

Orders ship in plain, unbranded packaging from our European fulfilment hub, usually within one working day of payment clearing. Standard delivery reaches all 27 EU + 3 EEA countries in 3–5 working days to most of them (2–7 depending on the country); express (1–2 working days) is also available. For EU orders, VAT and duties are settled at checkout via IOSS, so there are no surprise bills on arrival.

The active ingredient in Prosoma 350 — Carisoprodol Tablets is Carisoprodol. Always read the patient information leaflet and consult a doctor or pharmacist before first use.

Choose your method at checkout: secure bank/SEPA transfer or PayPal. You'll receive clear payment confirmation by email, and we dispatch within one working day of payment clearing.

Yes. Every order ships in plain, unbranded outer packaging — nothing on the outside indicates the contents or the pharmacy.

Prosoma 350 contains 350 mg of carisoprodol, a centrally acting muscle relaxant that causes drowsiness and carries a dependence risk; EU marketing authorisations for carisoprodol were suspended in 2008. Side effects and dependence risk increase with dose, and whether any dose suits you is your doctor's decision.

Carisoprodol carries a genuine dependence risk, particularly with prolonged use or doses above what the leaflet specifies. That is why courses are limited to a few weeks. Take it exactly as directed, do not extend the course on your own, and seek medical advice if you feel you need it to function day to day.

Drowsiness is the most common side effect of carisoprodol, alongside dizziness and headache. Do not drive, cycle, or operate machinery until you know how the tablets affect you. The sedative effect is most marked in the first hours after a dose.

The patient leaflet limits carisoprodol to short-term use, generally no more than two to three weeks, because acute muscle conditions usually resolve within that period and longer use increases dependence risk. If your pain has not improved by the end of the course, see your doctor rather than continuing or repeating it.

No. Alcohol and carisoprodol both depress the central nervous system, and together they can cause extreme drowsiness, poor coordination and dangerously slowed breathing. Avoid alcohol entirely for the duration of your course, not just around dosing times, since carisoprodol's active metabolite lingers in the body.

The leaflet explains how to take it, including in relation to food. Follow the leaflet and your doctor's schedule.

Carisoprodol itself has a half-life of roughly two hours, but its active metabolite meprobamate lasts around ten hours, so sedative effects can persist well beyond the initial dose. Standard drug screens may detect it for two to four days after your last tablet, longer with regular use.

No. The tablets are not scored for splitting, so fragments give unpredictable doses. If you feel the dose is wrong for you, speak to a doctor rather than improvising.

Yes — check the expiry date printed on the blister and box. Expired carisoprodol may lose potency and should not be taken. Because this is a short-course medicine, avoid stockpiling: buy what a course requires and dispose of leftovers via a pharmacy take-back rather than household waste.